Logo image of Y

Alleghany Corp (Y) Stock Fundamental Analysis

NYSE:Y - New York Stock Exchange, Inc. - US0171751003 - Common Stock - Currency: USD

847.79  0.01 (0%)

After market: 847.79 0 (0%)

Fundamental Rating

3

Overall Y gets a fundamental rating of 3 out of 10. We evaluated Y against 145 industry peers in the Insurance industry. Y may be in some trouble as it scores bad on both profitability and health. Y is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year Y was profitable.
Y had a positive operating cash flow in the past year.
Y Yearly Net Income VS EBIT VS OCF VS FCFY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 500M 1B 1.5B 2B

1.2 Ratios

Industry RankSector Rank
ROA 1.15%
ROE 4.49%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
Y Yearly ROA, ROE, ROICY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2 4 6 8 10

1.3 Margins

In the last couple of years the Profit Margin of Y has grown nicely.
Y's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 12.78%
PM (TTM) 3.02%
GM N/A
OM growth 3Y84.52%
OM growth 5Y23.94%
PM growth 3Y197.01%
PM growth 5Y17.76%
GM growth 3YN/A
GM growth 5YN/A
Y Yearly Profit, Operating, Gross MarginsY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 5 10 15

More info and screens

2

2. Health

2.1 Basic Checks

Y does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, Y has less shares outstanding
The debt/assets ratio for Y is higher compared to a year ago.
Y Yearly Shares OutstandingY Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 5M 10M 15M
Y Yearly Total Debt VS Total AssetsY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 10B 20B 30B

2.2 Solvency

The Debt to FCF ratio of Y is 1.16, which is an excellent value as it means it would take Y, only 1.16 years of fcf income to pay off all of its debts.
A Debt/Equity ratio of 0.30 indicates that Y is not too dependend on debt financing.
Although Y does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 1.16
Altman-Z N/A
ROIC/WACCN/A
WACC7.59%
Y Yearly LT Debt VS Equity VS FCFY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2B 4B 6B 8B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

More info and screens

6

3. Growth

3.1 Past

Y shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 43.36%, which is quite impressive.
Y shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 9.09% yearly.
The Revenue has grown by 12.10% in the past year. This is quite good.
Y shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.21% yearly.
EPS 1Y (TTM)43.36%
EPS 3Y41.72%
EPS 5Y9.09%
EPS Q2Q%-0.63%
Revenue 1Y (TTM)12.1%
Revenue growth 3Y19.03%
Revenue growth 5Y14.21%
Sales Q2Q%-11.07%

3.2 Future

The Earnings Per Share is expected to grow by 37.33% on average over the next years. This is a very strong growth
The Revenue is expected to decrease by -26.54% on average over the next years. This is quite bad
EPS Next Y53.69%
EPS Next 2Y37.84%
EPS Next 3Y37.04%
EPS Next 5Y37.33%
Revenue Next Year-62.15%
Revenue Next 2Y-36.68%
Revenue Next 3Y-30.32%
Revenue Next 5Y-26.54%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
Y Yearly Revenue VS EstimatesY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B
Y Yearly EPS VS EstimatesY Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 100 150

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

Y is valuated correctly with a Price/Earnings ratio of 15.90.
Y is valuated rather cheaply when we compare the Price/Earnings ratio to 27.50, which is the current average of the S&P500 Index.
Y is valuated reasonably with a Price/Forward Earnings ratio of 10.05.
Y's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.44.
Industry RankSector Rank
PE 15.9
Fwd PE 10.05
Y Price Earnings VS Forward Price EarningsY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF 5.68
EV/EBITDA 7.61
Y Per share dataY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 200 400 600 800

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
Y's earnings are expected to grow with 37.04% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.3
PEG (5Y)1.75
EPS Next 2Y37.84%
EPS Next 3Y37.04%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for Y!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Alleghany Corp

NYSE:Y (10/18/2022, 8:22:38 PM)

After market: 847.79 0 (0%)

847.79

0.01 (0%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)08-04 2022-08-04/amc
Earnings (Next)11-11 2022-11-11/amc
Inst Owners0.02%
Inst Owner Change0%
Ins Owners0.58%
Ins Owner Change0%
Market Cap11.41B
Analysts48
Price Target864.98 (2.03%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)8.25%
Min EPS beat(2)-2%
Max EPS beat(2)18.49%
EPS beat(4)3
Avg EPS beat(4)22.87%
Min EPS beat(4)-2%
Max EPS beat(4)73.15%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 15.9
Fwd PE 10.05
P/S 0.97
P/FCF 5.68
P/OCF 5.5
P/B 1.44
P/tB 1.82
EV/EBITDA 7.61
EPS(TTM)53.33
EY6.29%
EPS(NY)84.35
Fwd EY9.95%
FCF(TTM)149.26
FCFY17.61%
OCF(TTM)154.08
OCFY18.17%
SpS872.92
BVpS587.62
TBVpS467.02
PEG (NY)0.3
PEG (5Y)1.75
Profitability
Industry RankSector Rank
ROA 1.15%
ROE 4.49%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 12.78%
PM (TTM) 3.02%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y84.52%
OM growth 5Y23.94%
PM growth 3Y197.01%
PM growth 5Y17.76%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 1.16
Debt/EBITDA N/A
Cap/Depr 35.74%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 565.33%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC7.59%
ROIC/WACCN/A
Cap/Depr(3y)32.26%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)411.12%
Profit Quality(5y)537.55%
High Growth Momentum
Growth
EPS 1Y (TTM)43.36%
EPS 3Y41.72%
EPS 5Y9.09%
EPS Q2Q%-0.63%
EPS Next Y53.69%
EPS Next 2Y37.84%
EPS Next 3Y37.04%
EPS Next 5Y37.33%
Revenue 1Y (TTM)12.1%
Revenue growth 3Y19.03%
Revenue growth 5Y14.21%
Sales Q2Q%-11.07%
Revenue Next Year-62.15%
Revenue Next 2Y-36.68%
Revenue Next 3Y-30.32%
Revenue Next 5Y-26.54%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y148.38%
FCF growth 3Y68.09%
FCF growth 5Y18.55%
OCF growth 1Y143.87%
OCF growth 3Y66.59%
OCF growth 5Y18.6%